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Sclerosing epithelioid ﬁbrosarcoma (SEF) is a rare sarcoma of low-grade malignancy. There has been no report to describe the
comparison of histological features of SEF between primary and metastatic lesions in spite of high local recurrence rate. We
report the histological changes and increasing Ki-67 labeling index of the primary and metastatic lesions of SEF. The patient was
a 31-year-old man. At 18, a tumor in the abdominal wall was excised. At 23, the tumor recurred which was removed again. At
30, he was referred to our hospital because of swelling and pain in the chest. Histological examination of the chest wall tumor
showed epithelioid cells arranged like alveolar pattern with dense collagen stroma. These ﬁndings were consistent with those of
SEF. Abdominal and the rib tumors showed the same immunohistochemistrical expression. It is noteworthy that the tumor cells
of the rib lesion showed increased cellularity, and its Ki-67 activity was higher as compared with the abdominal tumor, suggestive
of progression of malignancy of SEF.
Copyright © 2009 Atsuko Kanno et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Sclerosing epithelioid ﬁbrosarcoma (SEF) is a very rare
sarcoma which occurs in the deep musculature. Extensive
English literature survey reveals that there have been only
ﬁfteen reports so far. There is wide age of spectrum and
median age is 45 and equal sex distribution [1].
It is ﬁrst reported by Meis-Kindblom in 1995. The
author described SEF as a variant of ﬁbrosarcoma simulating
carcinoma. This tumor is characterized by epithelioid cells
arranged in nest and strands in highly sclerosing matrix. SEF
is a relatively low-grade ﬁbrosarcoma histologically [2].
Ontheotherhand,highrateofrecurrenceandmetastasis
has been reported. Meis-Kindblom et al. reported that local
recurrence occurred in 53% and metastasis occurred in
43%. Their interval of metastasis was 4.7 to 14 years. In
some other cases, uncontrollable recurrence and metastasis
occurred after uneventful some years. They stated that SEF is
a clinically malignant sarcoma [3–5].
There is no report about the comparison of histological
characteristics of SEF between primary and metastatic
lesions in spite of high local recurrence rate. In some case
reports,thebiopsyfromthemetastasislesionwasperformed,
and the pathology was consistent with the primary lesion
[4–7]. However, there was no detailed description about the
grade of malignancy change except one report [6]. We report
an SEF patient, who had metastasis to the bones twelve years
after the initial operation, and the metastatic lesion of SEF
showed higher grade of malignancy than the primary lesion.
2.CaseReport
A 30-year-old man presented with 2-year history of bump
and pain in his left chest. In 1995, the soft tissue tumor of
abdominal wall was excised. In 2000, the recurrent tumor
was excised again. In January of 2007, he was referred to our
hospital. There was tenderness in the left chest. Radiological
examination revealed a lesion with bone destruction in
the left 6th rib (Figure 1(a)). CT revealed a pleural lesion.
Bone scintigraphy and positron emission tomography (PET)
showed increased uptake in the bilateral humeral shaft and2 Sarcoma
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Figure 1: (a) Plain radiogram showing bone destruction of the rib (arrow). (b) Bone scintigram showing increased spots in the bilateral
humerus and the left rib (arrow). (c) Plain radiogram of the left humerus showing an osteolytic lesion (arrow). (d) T1 weighted magnetic
resonance imaging showing gadolinium enhancement (arrow).
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Figure 2: the specimen of the abdominal tumor excised in 1995 showing abundant collagen proliferation (a) and alveolar pattern (b).
left rib (Figure 1(b)). Plain X-ray ﬁlms demonstrated an
osteolytic lesion in the humeral shaft (Figure 1(c)). The
cortex was thinned. MRI revealed the lesion in the left
humeral shaft with low signal intensities on T1 weighted
images and iso to high signal intensities on T2 weighted
images. The mass was enhanced after gadolinium injection
(Figure 1(d)).
Retrospective histological examination of the specimen
removed in 1995 revealed that the lesion was composed of
many spindle cells admixed with abundant collagen matrix
(Figure 2(a)). Epithelioid cells arranged in an alveolar pat-
tern(Figure 2(b)).Mitosiswasconspicuous.Itwasconsistent
with SEF.
The tumor removed from abdominal wall in 2000.
There was richness in abundant collagen. The features of
the tumor were similar to those of the previous surgery
specimen. However, this tumor showed increased cellularity.
In this specimen, epithelioid cells were more dominant
than spindle cells, and the epithelioid cells were arranged
in alveolar pattern (Figure 3). These cells showed nuclear
polymorphism, and increased frequency of mitosis 15 cells
per 10 high-power ﬁelds (HPF). Necrosis was found in
the specimen. This area revealed ghost-like ﬁgures. These
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Figure 3: The specimen of the abdominal tumor excised in 2000
showing epithelioid cells arranged in an alveolar pattern, too.
features well corresponded to SEF showing higher-grade
malignancy compared to the primary lesion.
To conﬁrm the diagnosis, excisional biopsy of the 6th
rib was performed. Macroscopically, the bone marrow was
occupied by a white solid tumor. Microscopically, the
specimen was composed of dysplastic cells in the hyalinized
stroma. These cells were arranged in epithelioid and alveolarSarcoma 3
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Figure 4: The specimen of the rib excised in 2007 showing cellular
atypia and prominent nuclear pleomorphism.
Figure 5:Ki-67stainingofthespecimenresectedin1995.Thereare
few Ki-67 positive cells. Ki-67 labeling index was 7 to 8%.
patternstoo.Incontrasttotheprimarylesion,thislesionwas
characterized by much higher cellularity, high nuclear/cell
rate, and more prominent nuclear polymorphism (Figure 4).
Mitosis was more prominent with 30 to 40 cells per 10
HPF. Necrosis was frequently found in the lesion. Ghost-like
ﬁgures were also present too.
Immunohistochemical examination revealed vimentin-
positive cells. Although it was focal, tumor cells were positive
for HHF-35. CD99 had a weak immunostaining pattern.
Tumor cells were negative for α-SMA, desmin, CD34, S-100
protein, cytokeratin (AE1/AE3), and epithelial membrane
antigen (EMA). All three specimens showed same features by
immunohistochemistry.
Ki-67 labeling indices were 7∼8%, 20%, and 60% in the
tumor excised in 1995, in 2000, and in 2007, respectively,
(Figures 5, 6,a n d7). In conclusion, the primary lesion was
SEF and that the lesion of the rib was bone metastasis from
SEF in the abdomen.
In February 2007, pathological fracture occurred in
the left humeral shaft. Since it was a metastatic lesion,
chemotherapy using ifosfamide and adriamycin was per-
formed. However, this chemotherapy was discontinued
because of acute myocardial infarction. Since the tumor size
is increasing, the patient was treated by radiation therapy to
the left humerus. After that, he hoped the second opinion, so
he was referred to another hospital.
Figure 6: The specimen resected in 2000. There were more Ki-67
positive cells than Figure 5. Ki-67 labeling index was 20%.
Figure 7: The specimen resected in 2007. More cells were stained
by Ki-67. Ki-67 labeling index was 60%.
3. Discussion
3.1. Histology of the SEF. SEF is characterized by uniform,
small, and round to ovoid epithelioid cells with clear
cytoplasm arranged in distinct nest and cords, embedded
in a hyalinized ﬁbrous stroma. This histology stimulates
inﬁltratingcarcinoma.Incontrast,therearehypocellularand
ﬁbromatous areas which contain spindle cells and abundant
collagen, simulating ﬁbroma [2]. There is the morphologic
variance in the sclerosing matrix. Antonescu et al. also
pointed out this, so the author described that “there was a
patchwork of zones of varying size, shape, and cellularity”i n
the SEF [3]. Eyden et al. described that all the SEF showed
variable cellularity in ﬁve cases [8]. In some other reports
variable cellularity was described [9, 10]. Hemorrhage and
necrosis were also occasionally seen [2, 6–8, 11].
In addition, the SEF is characterized by a range of other
morphologic appearance. Meis-Kindblom et al. described
that there were myxoid zones with cyst formation in the
SEF and that more cellular myxoid zones stimulated myxoid
ﬁbrosarcoma [2]. Antonescu et al. also reported that poorly
delineated myxoid area were present in four cases [3]. In
some reports there were ﬁbromatous zones which resemble
classic ﬁbrosarcoma [2, 3, 12, 13]. In addition, the staghorn
vessels, which were hemangiopericytoma pattern in some
reports [7, 11]. So, there are many diﬀerential diagnoses:4 Sarcoma
nodular fasciitis, desmoid, inﬁltrating carcinoma, monopha-
sic synovial sarcoma, clear cell sarcoma, hemangioperien-
dothelioma, sclerosing lymphoma, myxoid ﬁbrosarcoma,
and osteosarcoma.
In our case, polymorphic epithelioid cells arrange in
nest and strand, and there is much abundant collagen
and ﬁbroblasts. There is nuclear polymorphism too. It is
consistent with Meis-Kindblom’s report [2]. In addition,
histological analysis showed that mitosis and necrosis area
were much more frequently seen in the rib tumor than
the abdominal wall tumors resected in 1995 and in 2000.
Cellularity increased, which strongly suggests increasing
malignancy.
3.2. Immunohistochemical Feature. Meis-Kindblom descri-
bed that in most ﬁbrosarcoma, immunohistochemical stain-
ing was of limited value although it was useful for excluding
other lesions [2]. From past available reports described
in English [2–16], the only consistent ﬁnding is diﬀuse
reactivity for vimentin. Some cases express NSE [2, 6]a n d
S-100 protein [2, 12, 14] although they were weak or focal.
In some cases, tumor cells were positive for EMA, although
most of them were focal positive [2, 6, 10, 13, 14].
In the cases which were diﬃcult to diagnose, ultrastruc-
tural examination was performed and the features displayed
the features of ﬁbroblasts [2–8, 10, 11, 14].
In our case, vimentin was diﬀusely positive. Cytokeratin
and α-SMA were negative. Carcinoma, synovial sarcoma,
and epithelioid sarcoma were ruled out, and, CD34 was
negative, so hemangiopericytoma is less likely. Moreover,
three specimens (tumor resected in 1995, 2000, and 2007)
showed same feature by immunohistochemistry. So, we
concluded that these tumors are the same.
3.3. Proliferation Marker. Ki-67 is a nuclear antigen which
is expressed in late G1, S, M, G2 growth phases. In other
words, Ki-67 is expressed only when mitosis occur. There is
a correlation between high Ki-67 labeling index, especially,
more than 20%, and poor clinical diagnosis in soft tissue
sarcoma [17]. In some cases of SEF Ki-67 labeling index is
performed[2,7,10,11,13],Ki-67labelingindexwas1to5%.
Itisconsistentoflowmitoticrate,whichwere0to10mitoses
per 10 high-power ﬁelds. On the other hand, high rate of
local recurrence and distant metastasis are reported. Meis-
Kindblom concluded that neither proliferation markers nor
mitotic rate correlated with prognosis [2].
In our case, Ki-67 labeling index has changed among
three specimens. The abdominal tumor resected in 1995
showed 7 to 8% labeling index. The abdominal tumor
resected in 2000 showed 20%, the bone tumor of the rib
showed60%Ki-67labelingindex,respectively.Weconcluded
that malignancy grade has increased.
3.4. Clinical Feature. Clinically, in many cases of SEF local
recurrence [2–4, 7, 8, 12] and distant metastasis occurred
[2–8, 14]. Especially, uncontrollable local recurrence and
distant metastasis occur after the uneventful years. It is not
uncommon that metastasis occurs some years after primary
surgery [2, 3, 5, 14]. Meis-Kindblom reported that eight
patients had local recurrence in 15 patients and that the
medianintervaltotheﬁrstlocalrecurrencewas4.8years(2.3
to 11 years). The author also reported that six patients had
distant metastasis in 14 patients whose data were available
and that the median interval to metastases was 7.7 years (4.7
to 14 years) [2].
In our case, metastasis has occurred after 12 years. This
feature is consistent with these reports.
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